Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Cognitive Training for Patients With Schizophrenia [NA]
A completed clinical trial evaluating cognitive training for patients with schizophrenia and related disorders, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: D-serine Monotherapy for Schizophrenia [Phase 2]
A Phase 2 trial evaluating D-serine as monotherapy for schizophrenia has completed, sponsored by Herzog Hospital.
-
FDA approval · 2013-12-05FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for Versacloz (clozapine) submitted by TruPharma LLC. This action may involve updates to the pro…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Switching Medication to Treat Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating switching medications to treat schizophrenia has completed and results were posted in 2013.
-
CLINICAL_TRIALS research · 2013-12-05Clinical Trial Update: Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders [NA]
This clinical trial update describes a study evaluating pregnenolone and L-theanine augmentation for schizophrenia and schizoaffective disor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients [Phase 2]
A Phase 2 clinical trial is evaluating oxytocin in combination with social interventions for schizophrenia and schizoaffective disorder; the…
-
CLINICAL_TRIALS research · 2013-11-21Clinical Trial Update: F-18 Altanserin PET Study of Patients Receiving Clozapine [NA]
This clinical trial update describes a PET imaging study using F-18 altanserin in patients receiving clozapine, including individuals with s…
-
CLINICAL_TRIALS withdrawal · 2013-11-20Clinical Trial Update: Once Weekly D-cycloserine for Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating once-weekly D-cycloserine for schizophrenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone [Phase 4]
Phase 4 study evaluating satisfaction, quality of life, and effectiveness of flexible-dose paliperidone extended-release in adults with schi…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of iloperidone and risperidone for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia [NA]
A double-blind trial tested a probiotic supplement for reducing symptoms in schizophrenia and schizoaffective disorder; results were posted …
-
CLINICAL_TRIALS trial_result · 2013-11-12Clinical Trial Update: A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis [Phase 4]
A Phase 4 trial compared risperidone long-acting injection with an oral antipsychotic in early psychosis; results were posted in 2013 and in…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Broad Effectiveness: Study With Aripiprazole [Phase 3]
Phase 3 study evaluating aripiprazole investigates overall effectiveness in schizophrenia and schizoaffective disorder; the trial status is …
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 clinical trial evaluating the effects of adding aripiprazole to olanzapine in overweight patients with schizophrenia or schizoaffect…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders [Phase 2, Phase 3]
Trial update on an alternate formulation of aripiprazole for agitation in schizophrenia, covering Phase 2 and Phase 3 with the study status …
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia [Phase 4]
A Phase 4 trial evaluated three dosing regimens of aripiprazole in adults with acute schizophrenia and has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices [Phase 3]
A Phase 3 study evaluating aripiprazole for the management of schizophrenia in general psychiatric practice has completed, with results summ…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices [Phase 3]
This Clinical Trial Update reports the completion of a Phase 3 study evaluating aripiprazole for schizophrenia and schizoaffective disorder …
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Effect on Cognitive Function of a Treatment With Aripiprazole [Phase 4]
A Phase 4 trial evaluating the effect of aripiprazole on cognitive function in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia [Phase 3]
A Phase 3 clinical trial comparing aripiprazole and olanzapine for acute schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone [Phase 3]
A Phase 3 imaging study evaluating D2 receptor occupancy and fMRI brain responses in schizophrenia patients treated with lurasidone has comp…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients [Phase 4]
A Phase 4 study evaluating adjunctive aripiprazole in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Aripiprazole Oral Acceptability Trial [Phase 3]
A Phase 3 trial evaluating the oral acceptability of aripiprazole in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Treatment Response to Rehabilitation in Patients With Schizophrenia [NA]
The clinical trial evaluating rehabilitation to improve treatment response in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Schizophrenia Trial of Aripiprazole [Phase 3]
Completed Phase 3 trial update of aripiprazole for schizophrenia.